Skip to Content

Sionna Therapeutics Inc

Securities Class Action

  • Date:
  • 9/2/2026
  • Company Name:
  • Sionna Therapeutics Inc
  • Stock Symbol:
  • SION
  • Status:
  • Investigating

Case Finder

Locate any case using the tools below.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Sionna Therapeutics Inc (“Sionna Therapeutics” or the “Company”) (NASDAQ:SION) on behalf of Sionna Therapeutics stockholders. Our investigation concerns whether Sionna Therapeutics has violated the federal securities laws and/or engaged in other unlawful business practices.

On August 10, 2026, Sionna Therapeutics announced that its "SION-719 Phase 2a proof-of-concept trial did not achieve key activity endpoint of sweat chloride reduction when added to standard of care."
On this news, the price of Sionna Therapeutics stock fell more than 91%.

If you purchased or otherwise acquired Sionna Therapeutics shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out the form below.  There is no cost or obligation to you.
Contact Instructions
Please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com with any questions.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Sionna Therapeutics Inc . BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: